GENE ONLINE|News &
Opinion
Blog

2025-03-04|

Gensaic Partners with Novo Nordisk in $354M Deal to Advance Precision Therapies for Cardiometabolic Diseases

by Bernice Lottering
Share To
Gensaic partners with Novo Nordisk in a $354M deal to develop precision therapies for cardiometabolic diseases. Image: Freepik.
Gensaic, Inc. has entered a collaboration with Novo Nordisk to explore next-generation precision therapies aimed at treating cardiometabolic diseases. The partnership, which could be worth …

Gensaic Partners with Novo Nordisk in $354M Deal to Advance Precision Therapies for Cardiometabolic Diseases Read More »

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
West Nile and Usutu Viruses Detected in Wild Carnivore Populations in the Netherlands
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Biotech Stock Performance Gap Widens During Second Quarter of 2026
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
Sean Kaufman Faces Senate Scrutiny Over Past Vaccine Safety Comments Ahead of Confirmation Hearing
2026-07-10
Penn State College of Medicine Receives $2.5 Million Grant for Street Medicine Program
2026-07-10
READ MORE
EVENT
2026-07-08
ISSCR (Regenerative Medicine &Cell Therapy)
Montreal, Canada
2026-07-15
BIO Asia-Taiwan 2026 (APAC Biotech & Investment)
Taipei, Taiwan
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
SEE MORE
Scroll to Top